Capital Advisory Group Advisory Services’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
Other funds holding XPH
WBG
HCIA
FCBT
Capital Advisory Group Advisory Services's XPH Position: Q3 2020 in Review
Capital Advisory Group Advisory Services sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q3 2020, closing a stake of 147 shares — an estimated $6K sold.
Capital Advisory Group Advisory Services first reported a position in XPH in Q1 2018 and held it in 4 quarters. The position peaked at $37K in Q2 2018. 72 funds tracked by Wall St. Rank hold XPH as of Q3 2020.
- Capital Advisory Group Advisory Services reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q3 2020 after selling out during the quarter.
- Capital Advisory Group Advisory Services sold 147 State Street SPDR S&P Pharmaceuticals ETF shares in Q3 2020, an estimated $6K.
- Capital Advisory Group Advisory Services first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q1 2018 and held it in 4 quarters.
- Capital Advisory Group Advisory Services's State Street SPDR S&P Pharmaceuticals ETF position peaked at $37K in Q2 2018.
- 72 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2020.
Based on Capital Advisory Group Advisory Services's 13F filing for Q3 2020, filed 16 Nov 2020.